BioHealth News Archive
EU pays $384 million for Sanofi-GSK COVID vaccine as WHO scheme deadline looms | Reuters
BRUSSELS/PARIS (Reuters) - The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi SASY.PA and GSK GSK.L in its second such…
Read More
Qiagen completes takeover of PCR automation player NeuMoDx for $248M | MedTech Dive
Qiagen signed up to distribute the mid- and high-throughput versions of NeuMoDx’s PCR automation systems in major markets outside the U.S. in 2018. The…
Read More
Bio and Pharma Manufacturing Renaissance – YouTube
Bio and Pharma Manufacturing Renaissance https://www.youtube.com/watch?v=PwqTWD7Ifcs&feature=youtu.be
Read More
Roche receives U.S. emergency approval for coronavirus vs. flu test | Reuters
ZURICH (Reuters) - Drugmaker Roche on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug Administration for a test…
Read More
Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer (2)
HOUSTON, Sept. 9, 2020 /PRNewswire/ -- Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood…
Read More
Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer
HOUSTON, Sept. 9, 2020 /PRNewswire/ -- Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood…
Read More
Biotech-focused investor SR One is looking to raise $400m for its new fund | AltAssets Private Equity News
SR One, a venture capital firm focused on the biotech space, is looking to raised up to $400m for its new fund. The firm…
Read More
Emergent Biosolutions pumps $75m into Canton facility – News – Canton Journal – Canton, MA
Emergent BioSolutions will further strengthen its contract development and manufacturing capabilities by expanding into viral vector and gene therapy by investing $75 million in…
Read More
Aurinia Pharmaceuticals Prepares for Commercial Launch from New Maryland Site on the Heels of 2020 Hiring Spree · BioBuzz
Aurinia Pharmaceuticals (Aurinia) is a late-stage clinical biopharmaceutical company (Toronto Stock Exchange (TSX:AUP); NASDAQ (NASDAQ:AUPH) focused on commercializing therapies for rare autoimmune and inflammatory…
Read More
21 Emerging Life Science Companies Fueling Maryland’s Biohealth Ecosystem · BioBuzz
Maryland is the epicenter of biotech and life science innovation in the BioHealth Capital Region (BHCR). The state is home to a burgeoning life…
Read More
Graybug Vision files for $86 Million IPO on NASDAQ · BioBuzz
Graybug Vision, an Ocular disease biotech, filed with the SEC on September 4, 2020 for an $86 million IPO on the Nasdaq Global Market under…
Read More
GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo | Maryland | curated.tncontentexchange.com
BALTIMORE, Sept. 14, 2020 /PRNewswire/ -- GlycoT Therapeutics LLC, a UM Ventures start-up company based on intellectual property (IP) developed at the University of Maryland, Baltimore (UMB) and…
Read More
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
Doylestown PA, USA and Abingdon, Oxon, UK, 15 September 2020 – Emergex Vaccines Holding Limited (‘Emergex’), a company tackling major global infectious disease threats…
Read More